Healthcare

Addiction Biotech Cannabis Genetics Healthcare Medical Devices Pharmaceutical Science Veterinary
News Release Digital Asset Direct

Electronic Caregiver Presents Next Generation of Remote Patient Monitoring Technology With Virtual Caregiver at 2022 HIMSS Global Health Conference

Electronic Caregiver

Electronic Caregiver, a national digital health technology and services company, will debut Addison, the Virtual Caregiver, at the 2022 HIMSS Global Health Conference in Orlando, Florida, March 14-18. Addison is the next generation of remote patient monitoring (RPM) technology and offers a solution to the global caregiver crisis and the ongoing COVID-19 challenges by providing health care management outside the doctor’s four walls. Addison, anticipated to be released later this year, is a state-of-the-art, 3D-animated caregiver with an endearing personality. The Virtual Caregiver is designed to engage with and help monitor the health of aging and chronically ill clients, as well as child patients via touch-screen devices strategically placed throughout a residence. “Addison is a revolutionary new tool for use by providers to optimize patient care – monitoring, increasing treatment adherence, and improving health outcomes,” said Electronic Caregiver CEO Anthony Dohrmann. “Whether a patient with one or more morbidities requires assistance at home to follow complex medication regimens, comply with physical therapy, monitor vitals, or requires increased support for managing behavioral health conditions, Addison has the capabilities to extend care from provider to home.” Powered by Amazon Web Services (AWS) and Intel, Addison helps monitor patients’ health by providing voice-driven medication reminders, ensuring patients are following their doctor’s treatment plans, and offering 24/7 emergency response and telehealth services. Addison can also lead patients through the steps of recording a vital, such as blood pressure, oxygen saturation levels, and temperature, with the ability to share that information with designated providers and caregivers in real time. Addison gives a face and personality to the RPM experience. The Virtual Caregiver can also be customized to fit users’ preferences. Clients can choose from eight avatars of different ethnicities and genders to interact with, and Addison’s environment can mirror client lighting and weather automatically. Electronic Caregiver will present Addison, the Virtual Caregiver, in addition to its other RPM technology alongside Care Management company MD Revolution, Inc. at HIMSS Booth 4109. In 2020, Electronic Caregiver formed a partnership with MD Revolution, a provider of full-suite RPM and Chronic Care Management (CCM) solutions, to provide health practices with the technology and services to monitor patients remotely. “Through our highly productive partnership, we’re already delivering a 21st century health care experience for thousands of patients, and we’re confident our joint capabilities will scale to all the innovative health care providers in America,” said Kyle Williams, CEO of MD Revolution. “Our common goals are clear: to create more health care delivery capacity and to drive better patient outcomes. I’m confident we will continue to augment the traditional medical practice by building trust one patient at a time, one provider at a time.” MD Revolution offers Electronic Caregiver’s Pro Health, a 24/7 chronic care and monitoring system, as its preferred RPM device. The Pro Health includes a cellular-based console for the home and wearable wrist pendant for care support on the go. Like Addison, the Pro Health offers emergency response and health care management and can be paired with a multitude of Bluetooth devices to track vitals in real time. Devices are ordered, provisioned, and shipped directly to patients, with no up-front cost and no long-term commitment to the practice. MD Revolution has integrated the Pro Health into its HIPAA-compliant digital care management platform, called RevUp, which will be showcased during HIMSS. RevUp allows patient information to be securely monitored by a licensed care coordination team working as an extension of the provider practice. RevUp data is available with seamless, universal integration into the electronic health record (EHR), allowing for more proactive care by leveraging objective data and trend analysis. The solution also includes integrated care documentation, automated claims creation, and full-service marketing and enrollment services – resulting in more enrollments and faster reimbursement. Together, Electronic Caregiver and MD Revolution provide better outcomes, improved adherence, and simplified compliance management through sustainable telecare optimized for scale, economics, and services. Utilizing Electronic Caregiver’s technology, MD Revolution’s RevUp platform makes RPM implementation easy, supporting providers through the evolution of their practice. RevUp merges technology with traditional healthcare, seamlessly integrating with a provider’s day-to-day while upholding their practice's long-standing values. “We are reducing the number of office visits, ER visits, urgent care visits. So, the volume to medical facilities will very likely be reduced because we can monitor patients at home,” said MD Revolution client Dr. Edward Wingfield of Hamilton Cardiology Associates in New Jersey. “A lot of times, we bring patients in to just get a blood pressure or just to get a weight to make sure they are not going into heart failure. If all these things can be done remotely and we can act on it, it will cut medical costs.” About Electronic Caregiver Electronic Caregiver is a privately held digital health technology and services company headquartered in Las Cruces, NM (USA). ECG's mission is to design and deliver innovative, impactful telehealth products and services that bridge the chasm between the doctor's office and the patient's home to improve outcomes, expand access, and optimize resource allocation. ECG has been qualified as a technology solution provider in the Amazon Partner Network (APN). The company's solutions are available through health care organizations, physician practices, care management firms, home care agencies, and senior housing providers. www.electroniccaregiver.com About MD Revolution, Inc. MD Revolution, Inc. is an innovative Care Management company uniquely combining technology, services, and analytics to produce scalable, high-touch care models that enrich the patient-provider experience, improve the health of millions of patients, and enhance the profitable, effective practice of medicine for thousands of providers. MD Revolution’s remote care programs mitigate the challenges associated with meeting the requirements for Medicare’s Chronic Care Management (CCM), Remote Patient Monitoring (RPM), RPM for RHC/FQHC’s, Behavioral Health Integration (BHI), Annual Wellness Visits (AWV) and population health programs. Solutions are available as turn-key solutions, software-as-a-service, and through reseller partners. www.mdrevolution.com Contact Details Stephanie Guadian, Director of Public Relations +1 575-649-4604 sguadian@ecg-hq.com Alexia Severson, Public Relations Associate +1 575-993-9612 aseverson@ecg-hq.com

March 03, 2022 01:27 PM Mountain Standard Time

Image

Kramer launches its new high-performance, highly scalable KDS-7 AVoIP streaming solution

Kramer Electronics

Kramer Electronics Ltd. is pleased to announce the release of KDS-7, a full AVoIP streaming solution for anywhere that low-latency, high-quality 4K60 content distribution and switching is required. Delivering a superb user experience, enterprise IT-grade security and advanced, yet intuitive management, the KDS-7 line is a perfect fit for Enterprise, Education, Homeland Security, Military or Government sites of any size. Built as a complete solution, the KDS-7 product line comprises a full range of networked end points, including encoders, decoders and auto-switch encoders, as well as a dedicated manager device. It supports 1K video sources and easily scales to suit the AV needs of numerous rooms and locations, for any size business or campus. Enterprise-grade IT security, built-in to all KDS-7 devices, protects the IT network. The KDS-7 product line expands the benefits of AVoIP. With AVoIP, the AV encoders and decoders are connected to the end-points of the organization’s IP network. Leveraging the switching power of the IP network eliminates the limits on AV deployments, which would otherwise be constrained by the number of physical AV ports on hardware, and that consume a great amount of real estate and energy. This simple and reliable approach enables huge numbers of devices in a single network and makes expanding into new spaces easier and less costly. Kramer’s AVoIP offering is already widely recognized for providing optimum scalability and flexibility, with multiple solutions adopted at growing scale by Enterprise, Education, Homeland Security, Military and Government organizations. Now, with the KDS-7 line, Kramer is introducing even greater scalability and flexibility. Plug-and-play integration into any IP network speeds up deployment and significantly reduces costs. High-resolution video, support for large-scale video wall installations, and full compatibility with end-user devices, including USB-C connection for simple collaboration and simultaneous charge, ensure an outstanding experience for users. “At Kramer we’re proud to be a leader in creating AVoIP products that accelerate hybrid work, improve hybrid learning across campuses and enhance performance of command and control centers at large-scale installations,” commented Gilad Yron, CEO Kramer Electronics. “Our new KDS-7 AVoIP product line furthers our mission, providing a superior user experience with its ability to support a large number of video sources, with low latency, fast switching, intuitive manageability and advanced security capabilities.” We are dedicated to delivering better, smarter solutions that enhance physical-digital engagement and collaboration. Kramer solutions are based on our cutting-edge products and technologies for traditional AV, AV over IP, unified communication and collaboration (UCC) and wireless collaboration, and advanced management and control. Contact Details Kramer Electronics Ltd. Ornit Sade Benkin +972 52-332-7700 osade@kramerav.com Company Website https://www.kramerav.com/

March 03, 2022 09:00 AM Eastern Standard Time

Kadimastem Receives Grant for a Total Budget of NIS 10 Million ($3.1 million) from the Israeli Innovation Authority

Kadimastem

Kadimastem Ltd. (TASE: KDST), a clinical stage cell therapy company developing a treatment for ALS and a potential cure for diabetes, has received a grant from the Israel Innovation Authority (IIA) for a total budget of NIS 10 million ($3.1 million) and a net grant of NIS 4 million ($1.25 million). The grant will support the Company’s FDA IND enabling studies For its next clinical trial in ALS patients The funds will be used to advance the filing of an IND with the FDA by the end of 2022, to secure the approval of the FDA of the anticipated Phase IIa, US, multicenter, clinical trial protocol of AstroRx® for the treatment of ALS and expand the use of AstroRx® cell product for other neurological conditions such as multiple sclerosis and glaucoma. Kadimastem CEO Asaf Shiloni said, "This grant is an important expression of trust by the Israeli Innovation Authority in Kadimastem and the potential of our clinical, cell therapy platform to provide millions of patients worldwide with life-saving treatments. The Company is currently in one of the most significant periods in its history, both clinically and financially. We are scaling-up for a Phase IIa clinical trial of AstroRx® for ALS in the US as well as preparing to list on NASDAQ. This grant provides us with the necessary resources to advance both sets of plans.” Prof. Michel Revel, Chief Scientist of Kadimastem: "We thank the Innovation Authority for supporting Kadimastem, its work and its vision." This is the second grant awarded to Kadimastem in the past months by the IIA. The previous grant was earmarked for the scale-up of the production of AstroRx® as well as for creating a frozen, off-the-shelf product, to ensure the clinical quality of the product for patients worldwide. In 2019, Kadimastem completed a first-of-its-kind, Phase I/IIa clinical trial of AstroRx®, whereby the treatment was injected into the spinal cord fluid of 10 patients in a standard lumbar puncture procedure. AstroRx® showed high safety profile and significantly slowed the rate of disease progression for 3 months following treatment, as measured by the ALSFRS-R. Dr. Michal lzrael, VP of R&D said, “The grants the Company has received from the IIA for the development and clinical production of Kadimastem’s cellular, off-the-shelf AstroRx® product are a clear recognition of the company's innovative technology. Astrocytes, the support cells in the nervous system, which are the basis for the AstroRx® product, have enormous therapeutic potential to protect all types of nerve cells. We are working hard to bring a product to market that will help to improve the lives of ALS patients worldwide as well as to development this therapy for other neurodegenerative diseases such as multiple sclerosis and glaucoma." About Kadimastem: Kadimastem is a clinical stage cell therapy company, developing and manufacturing "off-the-shelf", allogeneic, proprietary cell products based on its technology platform for the expansion and differentiation of Human Embryonic Stem Cells (hESCs) into functional cells. AstroRx®, the Company's lead product, is an astrocyte cell therapy in clinical development as a treatment for ALS. IsletRx is the Company's second product in development. IsletRx is comprised of functional pancreatic islet cells intended to treat patients with insulin dependent diabetes. IsletRx demonstrated safety and efficacy in a proof-of-concept preclinical study. Kadimastem was founded by Professor Michel Revel, CSO of the Company and Professor Emeritus of Molecular Genetics at the Weizmann Institute of Science. Professor Revel received the Israel Prize for the invention and development of Rebif®, a multiple sclerosis blockbuster drug sold worldwide. Kadimastem is traded on the Tel Aviv Stock Exchange (TASE: KDST). Forward Looking Statement: This document may include forward-looking information as defined in the Securities Law, 5728 – 1968. Forward-looking information is uncertain and mostly is not under the Company's control and the realization or non-realization of forward-looking information will be affected, among other things, by the risk factors characterizing the Company's activity, as well as developments in the general environment and external factors affecting the Company's activity. The Company's results and achievements in the future may differ materially from any presented herein and the Company makes no undertaking to update or revise such projection or estimate and does not undertake to update this document. This document does not constitute a proposal to purchase the Company's securities or an invitation to receive such offers. Investment in securities in general and in the Company in particular bears risks. One should consider that past performance does not necessarily indicate performance in the future. Contact Details Asaf Shiloni +972 73-797-1613 s.bazak@kadimastem.com Company Website https://www.kadimastem.com/

March 03, 2022 08:05 AM Eastern Standard Time

Image

3rd Annual Survey: CMOs Increasingly Being Tapped to Lead Growth in Difficult Business Environment in 2022

Chief Outsiders

Chief Outsiders, the nation’s largest and fastest growing firm offering fractional Chief Marketing Officer services with Fortune 500 experience, today revealed the results from the third annual survey of its CMOs on their 2022 outlook. The results speak to the changing expectations that the C-suite holds for CMOs, the impact of the pandemic and changing customer behaviors and preferences (among them those pertaining to ESG) on companies and companies’ marketing priorities. “While it seems that we finally have the worst of the pandemic behind us, the impact of Covid on the economy, on businesses’ growth prospects and on customer preferences and behaviors, will continue to be strongly felt for quite some time to come. More than ever, CMOs are being called upon to take the leading role in helping companies accelerate growth in this new environment, many of whom haven’t embraced digital marketing solutions in any significant way until now,” said Art Saxby, founder and co-principal of Chief Outsiders. “Since labor shortages also impact the marketing function, and technology makes remote work more viable than ever, fractional CMOs are rapidly becoming a natural option for an increasing number of CEOs faced with a need to hire specialized executive-level help for achieving their growth objectives,” said Pete Hayes, CMO and co-principal of Chief Outsiders. Key Survey Takeaways: Expectations for 2022 Respondents were mixed on their expectations for 2022, with 47 percent of CMOs surveyed reported having a pessimistic view on the New Year. 46 percent expected the economic circumstances to improve. See Table 1, Q15: ( N: 57) here. Impediments to growth in 2022 CMOs identified as main headwinds for companies’ growth a continued shortage of talent, on-going supply chain issues, inflation, and potential government Covid measures. In other words, CMOs expect that the uncertainty and longer-term impact of the pandemic will continue to weigh negatively on companies’ growth prospects. See Table 2, Q16: (N: 55) here. CEO priorities for CMOs In the current environment where an unprecedented confluence of quickly evolving economic and sociological factors impact not only what customer have to be spend, but also how they collect information on alternatives and what factors weigh in when they make a purchasing decision, CMOs are called upon by their CEOs, first and foremost, to set the growth agenda. Second is lead generation (filling the sales pipeline), and third is building the organization to achieve growth goals. 76.4 percent of respondents say the shift in growth emphasis is permanent, while 12.7 percent say it’s not. See Table 3, Q8: (N: 56) here. Importance of ESG Another important factor impacting growth prospects for businesses are changes in customer buying behavior that are not new but have been accelerated through - and because - of the pandemic. Important changes to behaviors, next to the digitalization of the buyer journey, include growing concerns with ESG where 69 percent of respondents said that a brand’s stance on environmental and social issues is somewhat important or extremely important to customers when making purchasing decisions. And more than 83 percent said that CMOs should take the lead in defining and activating a brand’s ESG initiatives. See Table 4, Q36: (N: 54) here. Capturing and managing 1st party B2B, B2C customer data Upcoming changes to companies’ ability to leverage third party data is an emerging challenge marketers will need to address. When asked where marketers can best capture and manage first party customer data, at in-person events came second to last (the owned website and social media came first) - the same picture can be seen for both B2B and B2C customers. See Table 5, Q27: (N: 55) for B2B and Table 6, Q28: (N: 48) for B2C here. CEO attitudes towards fractional CMOs CEOs also no longer need CMOs to be on payroll, let alone check in every morning at 08:00 AM. Increasingly, attitudes are becoming more positive towards fractional CMOs where 70 percent of respondents said that fractional CMOs are becoming ever more accepted by the C-suite, with only 18 percent indicating that only some CEOs are willing to work with fractional CMOs. See Table 7, Q11: (N: 56) here. The complete results of the survey available upon request. About this survey Chief Outsiders surveyed more than 60 CMOs with Fortune 500 experience in over 1,400 enterprise and mid-market companies on their perspectives of their marketplaces. This marks the third annual CMO survey on what to expect in market trends and company growth. About Chief Outsiders Chief Outsiders is the leading Fractional CMO firm that helps CEOs accelerate growth through the development and disciplined execution of well-crafted growth plans. The firm has more than 100 part-time, or fractional, Chief Marketing Officers (CMOs) engaged from coast-to-coast. Unlike traditional marketing and management consulting firms, each CMO has held the position of VP Marketing or higher at one or more operating companies, including many Fortune 500 firms. Chief Outsiders CMOs have served on the executive team of more than 1,400 client companies, driving growth strategy and execution plans by offering instant access to talent with highly customized and flexible engagements. Because of its market-based growth plans, quality of leadership, and experienced team, Chief Outsiders has been recognized for the past eight years by Inc. Magazine as one of the 5,000 fastest growing privately held companies in the US, and was recognized in 2019 as a Forbes Small Giant. Chief Outsiders’ CEO Art Saxby and Principal Pete Hayes are the co-authors of “The Growth Gears: Using a Market-Based Framework to Drive Business Success,” an Amazon #1 best-seller for business owners and CEOs. For additional information about the companies who trust Chief Outsiders as their premier source for business growth acceleration, click here. Contact Details Razor Sharp PR Ray Young +1 512-633-6855 ray@razorsharppr.com Company Website https://www.chiefoutsiders.com/

March 02, 2022 12:55 PM Pacific Standard Time

AmeriLife Adds ORCA Life & The Curry Group to Growing National Network

AmeriLife

AmeriLife Group, LLC (“AmeriLife”), a national leader in developing, marketing, and distributing life and health insurance, annuities and retirement planning solutions, announced today that it has partnered with ORCA Life, a Louisville, Kentucky-based insurance marketing organization (IMO) that specializes in the distribution of final expense insurance. In a related deal, AmeriLife also announced its acquisition of an ownership stake in The Curry Group, a final expense agency and division of ORCA Life. Per the agreements, terms of both deals were not disclosed. “A successful partnership is about more than the numbers — it’s about shared culture and values,” said Scotty Elliott, president of AmeriLife’s Life & Health Brokerage Distribution. “ORCA Life and The Curry Group demonstrate their values day in and out in both their service to their clients and their community. AmeriLife couldn’t be more excited to add these incredible, high-performing and high-character companies to our expanding distribution.” "Today’s announcement marks an exciting time for ORCA Life,” said Glenn Crabtree, founder and president of ORCA Life. “Our partnership with AmeriLife is going to allow us to be on the cutting edge of the marketing tools, technologies and capabilities we need to be competitive and successful in today’s market, while taking agent profitability to a whole new level.” ORCA Life’s roots go back to the late ‘90s. Over the last two decades, it has expanded its footprint through grassroots marketing. The company was officially founded in 2016 to fill a glaring void in the final expense industry, emphasizing an in-home, face-to-face service model that has allowed its agents to cultivate meaningful relationships with their clients and better support seniors’ insurance needs for their final days. Today, ORCA Life boasts a growing roster of writing agents throughout and beyond the Midwest and Southeast. It continues to set the standard for client trust, care and excellence, helping it achieve industry recognition as a final expense market leader. The Curry Group, and owners and co-principals David and Lindsey Curry, were founding members of ORCA Life and have played a key role in building and sustaining the company’s success and upward trajectory. Under the leadership of David and Lindsey, The Curry Group is positioned to continue as ORCA Life’s most significant source of distribution, working to accelerate its success while maintaining focus on value-based service and leadership. “We are so thankful to be alongside Glenn and ORCA Life on this journey, but we are most excited for the future and opportunity to expand and excel with AmeriLife," said David Curry. "Our strategic partnership will charge our business, and allow us to collaborate and learn from high-performing talent that has been there and done that." “What we are most excited about is the level of leadership that The Curry Group can now tap into,” added Lindsey Curry. “John Maxwell said ‘everything rises and falls on leadership,’ and the leadership that we’ve experienced with AmeriLife is something we’re excited to be a part of.” ORCA Life will continue to operate as a stand-alone organization and be led by Crabtree and Vice President of Operations Scott Morris. The team will report to Elliott and be based at its Louisville headquarters. Likewise, The Curry Group, also based in Louisville, will continue to operate as part of ORCA Life and be led by David and Lindsey Curry. ### About AmeriLife AmeriLife’s strength is its mission: to offer insurance and retirement solutions to help people live longer, healthier lives. In doing so, AmeriLife has become recognized as the leader in developing, marketing, and distributing life and health insurance, annuities and retirement planning solutions to enhance the lives of pre-retirees and retirees across the United States. For more than 50 years, AmeriLife has partnered with top insurance carriers to provide value and quality to customers served through a national distribution network of over 300,000 insurance agents and advisors, more than 50 marketing organizations, and 50 insurance agency locations. For more information, visit AmeriLife.com, and follow AmeriLife on Facebook and LinkedIn. Contact Details AmeriLife Public Relations Jeff Maldonado +1 321-297-1112 jmaldonado@amerilife.com AmeriLife Corporate Development Patrick Nichols +1 727-726-0726 pnichols@amerilife.com Company Website https://amerilife.com/

March 02, 2022 10:00 AM Eastern Standard Time

Chew on This: How Choosing Almonds Can Help Jumpstart Your Wellness Routine

YourUpdateTV

A video accompanying this announcement is available at: https://youtu.be/KK3MSRsDCKA Now a few months into 2022, sticking to New Year resolutions may be challenging, whether that means finally attending spin class, starting a daily meditation practice, making healthier food choices, or all the above. The current reality is more people are home, and snacking more frequently, but there is a conflict between people wanting to be healthier yet craving indulgent food and snacks. Lack of routine and unlimited kitchen access coupled with added anxiety and stress is the perfect storm for mindless eating. Many of us recognize what wellness looks likes and the benefits of maintaining a wellness routine but aren’t actually doing what we are saying. According to new survey conducted by Dynata and California Almonds – yielding a sample size of 6,000 adults representative of the U.S. adult population[1] – the majority of respondents agree that healthy eating (73%), exercise (70%), taking time to relax or meditate (69%), and practicing self-care (64 %) are top priorities. And 74% plan to continue to prioritize self-care and changes to their wellness habits as we emerge from the pandemic. Most of us consider wellness important in our lives, but less than half (47%) admit to practicing wellness rituals daily. Less than half (48%) report healthy eating as a regularly practiced wellness routine. We could all use a friend in wellness, aka, a reliable source to keep us feeling our best. Snacking on almonds is a great place to start: Almonds are rich in nutrients that contribute to improved mental well-being and feeling energized to be at your best A balanced, happy lifestyle includes at least one serving of almonds as an essential part of your daily wellness ritual. [1] The study yielded a total sample size of n=6,000 with a margin of error of ± 1% at a 90 percent level of statistical confidence. Subgroup analysis was conducted to understand nuances across audience segments, with a priority on the following: Millennials (n=1,573) Almond eaters (n=1,884; defined as weekly+) Millennial almond eaters (n=595; almond eaters defined as weekly+) Families with children in the household (n=1,641) One serving of almonds (28 grams) has 13 grams of unsaturated fat and only 1 gram of saturated fat. It also provides 6 grams of protein, 4 grams of fiber, 20 percent of recommended magnesium—which aids in the production of energy in the body—and 50 percent of your daily Vitamin E, a powerful antioxidant that promotes skin health and supports immunity. For more information visit: www.almonds.com Contact Details YourUpdateTV +1 212-736-2727 yourupdatetv@gmail.com

March 02, 2022 09:00 AM Eastern Standard Time

Video

LevLane Advertising Announces SVP, Partnerships and Development

LevLane

LevLane Advertising, a full-service, award-winning advertising agency based in Center City, Philadelphia, has announced Carl Cherkin, former Vice President of Communications and Business Development at Philadelphia Union, as the agency’s first Senior Vice President of Partnerships and Development. LevLane is a nationally recognized agency which offers creative services, brand planning, social media strategy, public relations, analytics, and more. It was founded almost 40 years ago and has grown to employ more than 75 full-time employees today. Bruce Lev, LevLane’s CEO, Chief Creative Officer, and co-founder, said that while driving in new business and expanding the agency’s presence in the region are primary goals for Cherkin, he fully expects him to step in and contribute in areas outside of partnerships and development. “That’s just who Carl is, and the exact reason we brought him onto our team.” In his previous role at Philadelphia Union, Cherkin was a member of the executive team responsible for launching Philadelphia Union, the city’s successful Major League Soccer team, where he remains a consultant, now in his 13 th season with the club. In addition to the ground-breaking launch, he established a number of successful relationships with corporate sponsors, Chambers of Commerce, and a vast and varied array of businesses, while continuing to generate a continuum of profitable business development opportunities at all levels for the club. Prior to his work in business development and communications, he had a successful career spanning decades in journalism and public relations. For Cherkin, the transition from Emmy Award-winning television sportscaster to business development executive was natural. “I’ve spent my entire career making connections and building relationships, it’s what I love to do,” he said. “I am looking forward to being a part of the team that pushes LevLane into its next phase of growth. We have incredible talent here and my hope is that our reputation for attracting creative powerhouses and impressive clientele makes us the number one agency in Philadelphia and mid-Atlantic region.” The agency has experienced steady growth throughout the past several decades—the decision to bring on a senior vice president for partnerships and development ensures that the agency as a whole remains energized. ‘‘This is an exciting time for LevLane and for me as well. I’ve been given a unique opportunity to work in an environment where the culture, already created, is so vitally important. That my lifelong friend Bruce Lev has been the driving force behind that culture, makes it that much more meaningful,” said Cherkin. “It’s incredibly motivating and at the same time challenging, to know that any and all of contributions I make to this extraordinary group of people will continue to enhance the growth and success of LevLane and its clients.” About LevLane LevLane is an award-winning, full-service, independent advertising agency in Philadelphia, PA, that has been building brands that people love for nearly 40 years. Contact Details Lauren Stralo +1 610-401-4825 lstralo@levlane.com Company Website https://www.levlane.com

March 01, 2022 08:07 AM Eastern Standard Time

Image

Global Advanced Metals Declared Conformant to Minerals Due Diligence Audit Standard for Twelve Consecutive Years

Global Advanced Metals

Global Advanced Metals Pty Ltd (GAM), a leading producer of tantalum powders, additive manufacturing powders, and metallurgical products, has successfully undergone conflict minerals due diligence audits by the Responsible Minerals Assurance Process (RMAP) of the Responsible Minerals Initiative (RMI). Following the September 2021 audits, RMAP-RMI has determined GAM Aizu, Japan and Pennsylvania, USA facilities conformant to its audit standard for the twelfth time. “Successful RMI-RMAP audits are a reflection of GAM’s holistic approach to due diligence, which includes strategic engagement and collaboration with organizations like the Public Private Alliance for Responsible Minerals Trade (PPA), the Responsible Minerals Initiative (RMI), and the Organization for Economic Cooperation and Development (OECD) Multi-Stakeholders Group among others.” said Mark Lackey, GAM Vice-President of Global Operations The RMI-RMAP conflict-minerals due diligence audit program is led and supported by a cross section of industries (e.g., Electronics, Aerospace, Automotive), governments, and other stakeholders. Downstream companies rely on the compliance of smelters like GAM to comply with US Dodd-Frank 1502, EU conflict minerals regulations, and other applicable regulations GAM will continue to enhance its management system approach to minerals due diligence through outreach activities such as: the June 2021 presentation at the D. R. Congo National Episcopal Conference Forum on the Management of Natural Resources and the Environment, and engagement with local University students to share the importance of the role of business in promoting ethical sourcing. About GAM A leading conflict-free tantalum producer, GAM has exclusive rights to the world’s largest industrial resources of tantalum ore located in Western Australia. GAM produces conflict-free tantalum powders and metallurgical products at its Pennsylvania, USA and Aizu, Japan plants for a range of industries including electronics, aerospace, automotive, medical and chemical processing. GAM’s smelting facilities in Japan and the USA were first declared “Conflict-Free” in 2010 under the former EICC/GeSI Conflict-Free Sourcing Initiative (CFSI) audit program and continue to maintain their conformance to the current (RMAP) standard. About RBA, RMI and RMAP The Responsible Business Alliance—RBA was formerly known as the Electronic Industry Citizenship Coalition—EICC, The Responsible Minerals Initiative (RMI) was formerly known as the Conflict Free Sourcing Initiative—CFSI, and The Responsible Minerals Assurance Process—RMAP was formerly known as the Conflict Free Smelter Program—CFSP. Contact Details Global Advanced Metals Jean-Paul Meutcheho +1 610-369-8165 JMeutcheho@globaladvancedmetals.com Company Website https://globaladvancedmetals.com/

March 01, 2022 08:03 AM Eastern Standard Time

G Medical Innovations’ G Medical Tests and Services to Expand COVID-19 Testing to 150+ Additional Locations Across California via a $5.2 Million Cash Purchase

G Medical Innovations Holdings

G Medical Tests and Services, Inc., a wholly-owned subsidiary of G Medical Innovations Holdings Ltd. (NASDAQ: GMVD), announce today that it has expanded its COVID-19 testing services to more than 150+ additional locations across California. The new testing sites include theme parks, schools, commercial properties, office complexes, public buildings, and mobile facilities. G Medical acquired the business conducting testing at the locations for a total of $5.2 million in cash, to be paid out in milestones. The new sites will enable processing of more than 200,000 COVID-19 PCR and rapid antigen/flu tests, with anticipated revenues of $20 million over the next several months - with longer-term growth expected via direct-to-consumer health solutions. The company also reports it has repaid $2.5 million in cash on a $5 million convertible loan issued by Lind Partners. G Medical expects to process more than 200,000 COVID-19 PCR and rapid antigen/flu tests from the new sites, which will generate anticipated revenues of more than $20 million for G Medical Tests and Services in the next several months. The need for convenient COVID-19 PCR, Rapid Antigen/Flu testing, personal healthcare monitoring continues along with the company’s Prizma Care remote patient monitoring directly to consumers. “Our sites create synergies between the ongoing need for testing and remote patient monitoring. The new locations will support our continued investment in direct-to-consumer infrastructure,” said Dr. Yacov Geva, President, and CEO of G Medical Innovations. “COVID-19 is now part of the fabric of our daily lives, and taking control of one’s own health, including daily monitoring of vital signs with our Prizma is more important than ever.” About G Medical Innovations G Medical Innovations Holdings Ltd. is an early commercial-stage healthcare company engaged in the development of next-generation mHealth and telemedicine solutions and monitoring service platforms. The Company’s solutions and services can empower consumers, patients, and providers to better monitor, manage and improve clinical and personal health outcomes, especially for those who suffer from cardiovascular disease (or CVD), pulmonary disease, and diabetes. The Company’s current product lines consist of its Prizma medical device (or Prizma), a clinical-grade device that can transform almost any smartphone into a medical monitoring device, enabling both healthcare providers and individuals to monitor, manage and share a wide range of vital signs and biometric indicators; its Extended Holter Patch System, a multi-channel patient-worn biosensor that captures electrocardiography (or ECG) data continuously, including its QT Syndrome Prolongation Detection Capabilities Patch. In addition, the Company is developing its Wireless Vital Signs Monitoring System (or VSMS), which is expected to provide full, continuous, and real-time monitoring of a wide range of vital signs and biometrics. Its monitoring services include provision of Independent Diagnostic Testing Facility (or IDTF) monitoring services and private monitoring services. Visit https://gmedinnovations.com/. Forward-Looking Statements This press release contains forward-looking statements within the meaning of the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995 and other Federal securities laws. Words such as “expects,” “anticipates,” “intends,” “plans,” “believes,” “seeks,” “estimates,” and similar expressions or variations of such words are intended to identify forward-looking statements. For example, G Medical is using forward-looking statements when it discusses milestone payments, that it expects to process more than 200,000 COVID-19 PCR and rapid antigen/flu tests from the new sites and anticipated revenue. Because such statements deal with future events and are based on G Medical’s and McDade Products’ current expectations, they are subject to various risks and uncertainties, and actual results, performance, or achievements of G Medical and McDade Products could differ materially from those described in or implied by the statements in this press release. The forward-looking statements contained or implied in this press release are subject to other risks and uncertainties, including those discussed under the heading “Risk Factors” in G Medical’s prospectus filed pursuant to Rule 424(b)(4), filed with the Securities and Exchange Commission (“SEC”) on June 28, 2021, the registration statement on Form F-1 filed on February 14, 2022 (registration no. 333-262724) and in any subsequent filings with the SEC. Except as otherwise required by law, the companies undertakes no obligation to publicly release any revisions to these forward-looking statements to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events. References and links to websites have been provided as a convenience, and the information contained on such websites is not incorporated by reference into this press release. G Medical and McDade Products are not responsible for the contents of third-party websites. Contact Details G-Medical Innovations Kobi Ben-Efraim, CFO +972 8-958-4777 service@gmedinnovations.com Company Website https://gmedinnovations.com/

March 01, 2022 07:00 AM Eastern Standard Time

1 ... 235 236 237 238 239 ... 306